Literature DB >> 29423788

Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma.

Ji Hyae Lim1, Bom Yi Lee1, Jin Woo Kim1, You Jung Han2, Jin Hoon Chung2, Min Hyoung Kim2, Dong Wook Kwak2, So Yeon Park1, Hee Back Choi3, Hyun Mee Ryu4,5.   

Abstract

PURPOSE: Recently, fetal placenta-specific epigenetic regions (FSERs) have been identified for quantification of cell-free fetal DNA (cff-DNA) for non-invasive prenatal testing (NIPT). The aim of this study was to evaluate the efficiencies of a column-based kit and magnetic bead-based kit for quantification of methylated FSERs from maternal plasma.
METHODS: Maternal plasma was extracted from normal pregnant women within the gestational age of 10~13 weeks (n = 24). Total cell-free DNA (cf-DNA) was extracted using a column-based kit and magnetic bead-based kit from the plasma of the same pregnant woman, respectively. Methylated FSERs were enriched from the extracted total cf-DNA using a methyl-CpG-binding domain-based protein method. The four FSERs were simultaneously quantified by multiplex real-time polymerase chain reaction.
RESULTS: Methylated FSERs were detected in all samples extracted from both kits. However, the amplification of FSERs showed significant differences in the extraction efficiency of methylated FSERs between the two extraction methods. The Ct values of methylated FSERs extracted using the column-based kit were significantly lower than those obtained using the magnetic bead-based kit (P < 0.001 for all FSERs). The quantity of methylated FSERs was significantly higher for extracted DNA using the column-based kit than that extracted using the magnetic bead-based kit (P < 0.001 for all FSERs). Time and cost for the process of extraction were similar for the column kit and magnetic bead-based kit.
CONCLUSIONS: Our findings demonstrate that the column-based kit was more effective than the magnetic bead-based kit for isolation of methylated FSERs from maternal plasma as assessed by FSER detection.

Entities:  

Keywords:  Cell-free fetal DNA; DNA extraction; Epigenetic markers; Non-invasive prenatal testing

Mesh:

Substances:

Year:  2018        PMID: 29423788      PMCID: PMC5949107          DOI: 10.1007/s10815-018-1114-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  21 in total

1.  Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses.

Authors:  X Y Zhong; M R Bürk; C Troeger; L R Jackson; W Holzgreve; S Hahn
Journal:  Prenat Diagn       Date:  2000-10       Impact factor: 3.050

2.  Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.

Authors:  Y M Dennis Lo; K C Allen Chan; Hao Sun; Eric Z Chen; Peiyong Jiang; Fiona M F Lun; Yama W Zheng; Tak Y Leung; Tze K Lau; Charles R Cantor; Rossa W K Chiu
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

3.  Early detection of cell-free fetal DNA in maternal plasma.

Authors:  S Illanes; M Denbow; C Kailasam; K Finning; P W Soothill
Journal:  Early Hum Dev       Date:  2007-01-16       Impact factor: 2.079

Review 4.  Fetal DNA in maternal plasma: progress through epigenetics.

Authors:  Y M Dennis Lo
Journal:  Ann N Y Acad Sci       Date:  2006-09       Impact factor: 5.691

5.  Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.

Authors:  M Alberry; D Maddocks; M Jones; M Abdel Hadi; S Abdel-Fattah; N Avent; P W Soothill
Journal:  Prenat Diagn       Date:  2007-05       Impact factor: 3.050

6.  Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.

Authors:  Robert W Old; Francesco Crea; William Puszyk; Maj Anita Hultén
Journal:  Reprod Biomed Online       Date:  2007-08       Impact factor: 3.828

7.  Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma.

Authors:  Fiona M F Lun; Rossa W K Chiu; K C Allen Chan; Tak Yeung Leung; Tze Kin Lau; Y M Dennis Lo
Journal:  Clin Chem       Date:  2008-08-14       Impact factor: 8.327

8.  Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21.

Authors:  Elisavet A Papageorgiou; Alex Karagrigoriou; Evdokia Tsaliki; Voula Velissariou; Nigel P Carter; Philippos C Patsalis
Journal:  Nat Med       Date:  2011-03-06       Impact factor: 53.440

9.  Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.

Authors:  Da Eun Lee; Ji Hyae Lim; Min Hyoung Kim; So Yeon Park; Hyun Mee Ryu
Journal:  J Mol Diagn       Date:  2016-03-04       Impact factor: 5.568

10.  Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21.

Authors:  Y M Lo; T K Lau; J Zhang; T N Leung; A M Chang; N M Hjelm; R S Elmes; D W Bianchi
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

View more
  7 in total

1.  Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.

Authors:  Longwei Qiao; Qin Zhang; Yuting Liang; Ang Gao; Yang Ding; Nannan Zhao; Wei Zhang; Hong Li; Yaojuan Lu; Ting Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

2.  Comparison of indications and results of prenatal invasive diagnostic tests before and after the implementation of the use of cell-free fetal DNA: a tertiary referral center experience.

Authors:  Firat Okmen; Huseyin Ekici; Ismet Hortu; Metehan Imamoglu; Duygu Arican; Haluk Akın; Sermet Sagol
Journal:  J Assist Reprod Genet       Date:  2020-05-21       Impact factor: 3.412

3.  Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma.

Authors:  Mostafa Akbariqomi; Reza Heidari; Soraya Saleh Gargari; Mir Davood Omrani; Garshasb Rigi; Nafiseh Sadat Sanikhani; Hamid Kooshki; Fatemeh Mahmoudian; Mohammad Ali Mazlomi; Gholamreza Tavoosidana
Journal:  J Assist Reprod Genet       Date:  2019-02-28       Impact factor: 3.412

Review 4.  Potential of Next-Generation Sequencing in Noninvasive Fetal Molecular Blood Group Genotyping.

Authors:  Sandra Wienzek-Lischka; Sandy Bachmann; Vanessa Froehner; Gregor Bein
Journal:  Transfus Med Hemother       Date:  2020-01-20       Impact factor: 3.747

5.  Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing.

Authors:  Jun Cao; Longwei Qiao; Jieyu Jin; Sheng Zhang; Ping Chen; Haoyu Tang; Zheng Yu; Jingye Shi; Ting Wang; Yuting Liang
Journal:  Front Med (Lausanne)       Date:  2022-01-12

6.  Appraisal on the Wound Healing Potential of Deverra tortuosa DC. and Deverra triradiata Hochst Essential Oil Nanoemulsion Topical Preparation.

Authors:  Reem A Kamel; Mohammed S Teiama; Ali M El-Hagrassi; Sabah H Elgayed; Mohamed A Khattab; Elsayed K El-Sayed; Magda T Ibrahim; Mohamed S Mady; Fatma A Moharram
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

7.  A novel method for extracting circulating cell-free DNA from whole blood samples and its utility in the non-invasive prenatal test.

Authors:  Hongbin Zhong; Liuhong Zeng; Mengyuan Tao; Yuchen Ye; Yanqi Wang; Lei Hou; Miaofeng Wu; Hui Liu; Hongyun Zhang; Meifang Tang
Journal:  Prenat Diagn       Date:  2022-08-05       Impact factor: 3.242

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.